NITI Aayog's Strategic Roadmap to Make Ayurveda a Global Healthcare Leader

#GS-2 #Governance & Social Justice #Health #GS-3 #Economy #Growth #Current Events #National #Ayurveda #NITI Aayog

Why in News

NITI Aayog released a report titled Strategic Roadmap for Making Ayurveda Global.
This report analyzes why Ayurveda stays behind Traditional Chinese Medicine (TCM) in international markets.
It outlines a phased action plan from 2025 to 2047 to help Ayurveda gain global recognition by India's independence centenary.

Exports of Ayurveda and herbal products grew from USD 1.09 billion in 2014 to USD 2.16 billion in 2023, reaching around 150 countries.
Nearly 30 countries now formally recognize Ayurveda using different licensing systems and academic partnerships.
India has over 355,000 trained Ayurveda practitioners, but 95% of them work only within India.
Research on Ayurveda takes place in nearly 70 countries, aided by the WHO Global Traditional Medicine Centre (GTMC) in Jamnagar, Gujarat.
Institutions like the University of Mauritius and Western Sydney University host Ayush academic Chairs, though a uniform global curriculum is missing.
The WHO included Ayurveda, Siddha, and Unani (ASU) in the ICD-11 classification under its TM-2 module.
The WHO started coding ASU treatments under the ICHI framework to improve tracking, billing, and global clinical research.

Ayurveda focuses on preventive health and overall wellness, matching the modern global demand for holistic healing.
Its Prakriti-based system uses plant therapies to provide personal health solutions for each individual.
Backed by over 5,000 years of knowledge, global Yoga adoption, and WHO ICD-11 inclusion, Ayurveda holds high cultural trust.
Ayurveda works well alongside modern medicine, especially for chronic diseases, preventive health, and rehabilitation.

Many foreign nations do not treat Ayurveda as an official medical system and lack clear regulations for it.
A shortage of certified Ayurveda doctors abroad and missing international study standards slow down its growth.
Because Ayurvedic treatment depends on the individual, producing Randomized Controlled Trial (RCT) evidence remains difficult.
High testing costs, uneven Good Manufacturing Practices (GMP) quality, and a lack of health insurance coverage limit foreign sales.

Programs like Ayush Chairs, Ayush Scholarships, and the Ayush Visa can help Ayurveda expand across borders.
Working closely with the GTMC and applying ICHI health codes will build international confidence in Ayurveda.
The USD 1 trillion global wellness market, alongside rising Medical Value Travel (MVT), offers huge growth options.
Conducting solid scientific research and sharing clear evidence will boost Ayurveda's international standing.

Lack of coordination between doctors, scientists, colleges, factories, and regulators delays international success.
Exporters sell most Ayurvedic goods as dietary supplements instead of prescription medicines, reducing their market value.
Rapid growth of Traditional Chinese Medicine (TCM), backed by government support, creates stiff competition.
Balancing core ancient Ayurvedic concepts with strict modern scientific rules remains a tough task.

TCM has over 34,000 licensed acupuncturists in the US across 47 states, while Ayurveda has only about 5,000 practitioners abroad.
Exports of TCM reach USD 5.4 billion, compared to USD 2.16 billion for Ayurveda in 2023.
China built over 30 overseas TCM centres using the Belt and Road Initiative (BRI), whereas India relies on Ayush Information Cells and the GTMC.
Countries like the US, Japan, and Germany offer health insurance for TCM, while Ayurveda insurance remains limited outside India.
TCM benefits from a dedicated ISO technical committee for quality standards, which Ayurveda currently lacks.

Form a high-level Mission Steering Group (MSG) under the Ayush Minister to guide trade, education, research, and diplomacy.
Launch a Global Ayurveda Register (GAR) under NCISM to verify credentials and offer professional training for global doctors.
Build a Global Information Portal offering clear details on foreign visas, licenses, and official health rules.
Speed up WHO-GMP quality certificates for top Ayurvedic medicine makers and publish a public directory of certified facilities.
Create an Export Edition of the Ayurvedic Pharmacopoeia that sets strict safety standards for raw materials and heavy metals.
Launch a real-time Ayurveda Trade Dashboard and assign accurate HS codes to boost trade under Free Trade Agreements.

Register main Ayurvedic medicines under the European Union (EU) Traditional Herbal Medicinal Products Directive (THMPD) framework.
Test medical insurance coverage for Ayurvedic remedies in selected OECD nations on a pilot basis.
Sign Mutual Recognition Arrangements (MRAs) with G20, BRICS, and ASEAN partners to allow doctors to work abroad easily.
Offer Ayurveda elective courses in foreign medical colleges using the existing Ayush Chair network.
Create medical tourism centers abroad, starting in Mauritius, with bundled Ayush Visa deals covering treatments and online follow-ups.
Conduct clinical trials in multiple countries via WHO Collaborating Centres and update the Traditional Knowledge Digital Library (TKDL).

Integrate Ayurveda officially into the national healthcare systems of at least 20 countries.
Secure health insurance cover in at least 10 countries for conditions like back pain, knee arthritis, stress, and women's health.
Establish a network of International Ayurveda Centres of Excellence providing medical care, training, research, and public health tracking.
Position Ayurveda globally as an evidence-backed, highly trusted healthcare choice by 2047.

NITI Aayog's roadmap turns Ayurveda from wellness spa treatments into a fully regulated global pharmacy system.
Combining ancient knowledge with modern scientific testing will help India match the international success of Traditional Chinese Medicine.
Standardized licensing and quality control convert India's cultural heritage into real economic strength.
This long-term effort aims to make Ayurveda a core pillar of worldwide healthcare by 2047.